Education
About Us
Working with TipRanks
Follow Us
Impact BioMedical, Inc. (IBO)
:IBO
Total Valuation
Impact BioMedical, Inc. has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Impact BioMedical, Inc. has 12,085,412 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,085,412
Owned by Insiders11.89%
Owned by Institutions0.15%
Financial Efficiency
Impact BioMedical, Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count2
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Impact BioMedical, Inc. is ―. Impact BioMedical, Inc.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Impact BioMedical, Inc. had revenue of ― and earned -4.41M in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income-4.03M
Pretax Income―
Net Income-4.41M
EBITDA-3.93M
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Impact BioMedical, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.65
52-Week Price Change-78.54%
50-Day Moving Average0.63
200-Day Moving Average―
Relative Strength Index (RSI)44.58
Average Volume (3m)7.14M
Important Dates
Impact BioMedical, Inc. upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Impact BioMedical, Inc. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Impact BioMedical, Inc. has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Impact BioMedical, Inc. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Impact BioMedical, Inc. has ― in cash and marketable securities with 8.01M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt8.01M
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Impact BioMedical, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―